There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The novel immunomodulator FTY720 is remarkably effective in models of transplantation
and autoimmunity. Recent data show that phosphorylated FTY720 is an agonist at four
sphingosine 1-phosphate receptors. Stimulation of sphingosine 1-phosphate receptors
leads to sequestration of lymphocytes in secondary lymphatic tissues and thus away
from inflammatory lesions and graft sites.